PDS Biotechnology
PDSB
PDSB
52 hedge funds and large institutions have $182M invested in PDS Biotechnology in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
52
Holders Change
+1
Holders Change %
+1.96%
% of All Funds
1.3%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
5
Increased
26
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $5K | 405 | +302 | +293% |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| $1K | 65 | -1,908 | -97% |
|
53
Asset Management One
Tokyo,
Japan
| – | – | -223,786 | Closed |
|
|
RC
54
RegentAtlantic Capital
Morristown,
New Jersey
| – | – | -22,500 | Closed |
|
|
TG
55
TLP Group
Evanston,
Illinois
| – | – | -9,792 | Closed |
|
|
MWP
56
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| – | – | -5,350 | Closed |
|